Medicine and Dentistry
Analysis of Covariance
14%
Cross Sectional Study
100%
Least Square Analysis
14%
Lower Urinary Tract Symptom
14%
Mirabegron
14%
Nocturia
28%
Outcome Assessment
42%
Overactive Bladder
100%
Overactive Bladder Treatment
14%
Patient-Reported Outcome
57%
Population
14%
Sleep Disorder
100%
Sympathomimetic Drug
14%
Treatment Group
57%
Keyphrases
Adrenergic Agonist
14%
Analysis of Covariance
14%
Antimuscarinics
14%
Between-group
14%
Bonferroni
14%
Least Mean Square
14%
Lower Urinary Tract Symptoms
14%
Mean Standard Deviation
14%
Mirabegron
14%
Nocturia
28%
Overactive Bladder Symptom Score (OABSS)
100%
Pairwise Testing
14%
Patient-Reported Outcomes Measurement Information System (PROMIS)
57%
Sleep Disturbance
100%
Sleep Outcomes
14%
Symptom Impact
14%
Symptom Score
28%
Temporal Association
14%
Treatment Group
57%
Treatment Type
14%
Nursing and Health Professions
Adrenergic Receptor Stimulating Agent
14%
Analysis of Covariance
14%
Information Systems
42%
Least Square Analysis
14%
Lower Urinary Tract Symptom
14%
Mirabegron
14%
Nocturia
28%
Outcome Assessment
42%
Overactive Bladder
100%
Patient-Reported Outcome
57%
Population
14%
Sleep Disorder
100%
Treatment Group
57%
Psychology
Analysis of Covariance
20%
Overactive Bladder
100%